MAIN PUBLICATIONS (2008-2018) (*Corresponding author; §: equal participation)
Voeltzel T*§, Flores-Violante M§, Zylbersztejn F, Lefort S, Billandon M, Jeanpierre S, Joly S, Fossard G, Milenkov M, Mazurier F, Nehme A, Belhabri A, Paubelle E, Thomas X, Michallet M, Louache F, Nicolini FE, Caron de Fromentel C, Maguer-Satta V*. (2018) A new signaling cascade linking BMP4, BMPR1A, ΔNp73 and NANOG impacts on stem-like human cell properties and patient outcome. Cell Death Dis. 9(10):1011. doi: 10.1038/s41419-018-1042-7. PMID: 30262802
Wu X, Kabalane H, Kahli M, Petryk N, Laperrousaz B, Jaszczyszyn Y, Drillon G, Nicolini FE, Perot G, Robert A, Fund C, Chibon F, Xia R, Wiels J, Argoul F, Maguer-Satta V, Arneodo A, Audit B, Hyrien O. (2018) Developmental and cancer-associated plasticity of DNA replication preferentially targets GC-poor, lowly expressed and late-replicating regions. Nucleic Acids Res 2;46(19):10157-10172. doi: 10.1093/nar/gky797. PMID: 30189101
Grockowiak E, Laperrousaz B, Jeanpierre S, Voeltzel T, Gobert S, Guyot B, Nicolini FE* and Maguer-Satta V*. (2017) Immature CML cells implement a BMP autocrine loop to escape TKI treatment. Blood. 130(26):2860-2871. doi: 10.1182/blood-2017-08-801019. PMID: 2913822
Bellanger A, Donini C, Vendrell J, Lavaud J, Machuca-Gayet I, Ruel M, Vollaire J, Grisard E, Győrffy B, Bièche I, Peyruchaud O, Coll JL, Treilleux I Maguer-Satta V, Josserand V and . Cohen P. (2017) The critical role of the ZNF217 oncogene in promoting breast cancer metastasis to the bone.. Journal of pathology. 242(1):73-89. doi: 10.1002/path.4882. PMID: 28207159
Clément F, Xu X, Donini C, Clement A, Omarjee S, Delay E, Treilleux I, Fervers B , Le Romancer M, Cohen P and Maguer-Satta V*. (2017) Long-term exposure to Bisphenol A or Benzo(a)pyrene alters the fate of human mammary epithelial stem cells in response to BMP2 and BMP4, by pre-activating BMP signalling. Cell Death Diff. 24(1):155-166. doi: 10.1038/cdd.2016.107. Epub 2016 Oct 14.PMID: 27740625
Laperrousaz B, Berguiga L, Nicolini FE, Martinez-Torres C, Arneodo A, Maguer-Satta V. Argoul F. (2016) Revealing stiffening and brittling of chronic myelogenous leukemia hematopoietic primary cells through their temporal response to shear stress. Phys Biol. 13(3):03LT01 doi: 10.1088/1478-3975/13/3/03LT01. PMID: 27254599
Clement F, Zhu HH, Gao W-Q, Delay E and Maguer-Satta V*. (2015) Update of a Protocol to Quantify Epithelial Early Common Progenitors from Long-Term Primary or Cell Lines Sphere Culture. Curr Protoc Stem Cell Biol. 35:1E.7.1-8. PMID: 26544537
Nicolini FE, Etienne G, Dubruille V, Roy L, Huguet F, Legros L, Giraudier S, Coiteux V, Guerci-Bresler A, Lenain P, Cony-Makhoul P, Gardembas M, Hermet E, Rousselot P, Amé S, Gagnieu MC, Pivot C, Hayette S, Maguer-Satta V, Etienne M, Dulucq S, Rea D, Mahon FX. (2015) Nilotinib and pegylated interferon alfa 2a for newly diagnosed chronic phase chronic myeloid leukaemia patients. Results of a multicentric phase II study. Lancet Hematology, 2 (1): e37-e46. PMID: 26687426
Chapellier C,and Maguer-Satta V*. BMP2, a key to uncover luminal breast cancer origin linked to pollutant effects on epithelial stem cells niche. (2015) Molecular & Cellular Oncology. 3(3):e1026527. DOI: 10.1080/23723556.2015.1026527. PMID: 27314065
Chapellier C, Bachelard-Cascales E, Schmidt X, Clement F, Treilleux I, Delay E, Jammot A, Menetrier-Caux C, Pochon G, Besançon R, Voeltzel T, Caron de Fromentel, Caux C, Blay JY, Iggo R and Maguer-Satta V*. (2015) Disequilibrium of BMP2 levels in the breast stem cell niche launches epithelial transformation by over-amplifying BMPR1B cell response. Stem Cell Reports, 4(2):239-254. PMID: 25601208
Laperrousaz B, Jeanpierre S, Sagorny K, Voeltzel T, Ramas S, Kaniewski B, Ffrench M, Salesse S, Nicolini FE, Maguer-Satta V (2013). Primitive CML cell expansion relies on abnormal levels of BMPs provided by the niche and on BMPRIb overexpression. Blood 122(23): 3767-3777. PMID: 24100446
Nicolini FE, Ibrahim AR, Soverini S, Martinelli G, Müller MC, Hochhaus A, Dufva IH, Kim DW, Cortes J, Mauro MJ, Chuah C, Labussière H, Morisset S, Roche-Lestienne C, Lippert E, Hayette S, Peter S, Zhou W, Maguer-Satta V, Michallet M, Goldman J, Apperley JF, Mahon FX, Marin D, Etienne G. (2013) The BCR-ABLT315I mutation compromises survival in chronic phase chronic myelogenous leukemia patients resistant to tyrosine kinase inhibitors, in a matched pair analysis. Haematologica. 98(10):1510-6. PMID:23716543
Bachelard-Cascales E, Chapellier M, Delay E and Maguer-Satta V*. (2012) A protocol to quantify Mammary Early Common Progenitors from long-term mammosphere culture. Curr Protoc Stem Cell Biol. Chapter 1:Unit 1E.7.PMID:22415837
Maguer-Satta V*, Chapellier M, Delay E and Bachelard-Cascales E. (2011) CD10: a tool to crack the role of stem cells in breast cancer. PNAS, 108(49):E1264. PMID:22109559
Maguer-Satta, V*. Besançon, R. and Bachelard-Cascales, E. (2011) Neutral endopeptidase (NEP/CD10): a multifaceted environment actor in stem cells, physiological mechanisms and cancer. Stem Cells. 29(3):389-96. doi: 10.1002/stem.592 ISBN 1066-5099, PMID:21425402
Cosset, E. Hamdan, G. Jeanpierre, S. Voeltzel, T. Sagorny, K. Hayette S. Mahon, F.-X Dumontet, C. Puisieux, A. Nicolini, F. E.and Maguer-Satta V*. (2011) Deregulation of TWIST-1 as a novel prognostic factor in chronic myeloid leukemia Blood. 3;117(5):1673-6. Epub 2010 Dec 1. ISBN, 0006-1971 PMID: 21123820
Bachelard-Cascales, E.. Chapellier, M. Delay, E. Pochon, G. Voeltzel, T. Puisieux, A. Caron de Fromentel C and Maguer-Satta. V*. (2010) The CD10-enzyme is a key player to identify and regulate Human mammary stem cells. Stem Cells 28,1081-88. PMID:20506111
Jeanpierre, S. Nicolini, FE. Kaniewski, B. Dumontet, C. Rimokh, R. Puisieux, A. and Maguer-Satta, V*. (2008) BMP-4 mediates TPO effects on megakaryocytic differentiation in human primary cells. Blood.112, 3154-3163
Berger, M. Richard, C. Berger, J. Jeanpierre, S. Nicolini, FE. Tournilhac, O. Michallet, M. and Maguer-Satta, V*. (2008). Fludarabine chemotherapy alter cell-to-cell interactions in BM stem cell niche, likely involved in stem cell mobilization failure. Leukemia. 22(11):2131-4